164 related articles for article (PubMed ID: 27660902)
1. Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study.
Volod O; Lam LD; Lin G; Kam C; Kolyouthapong K; Mac J; Mirocha J; Ambrose PJ; Czer LS; Arabia FA
ASAIO J; 2017; 63(1):24-31. PubMed ID: 27660902
[TBL] [Abstract][Full Text] [Related]
2. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping.
Corliss BM; Polifka AJ; Harris NS; Hoh BL; Fox WC
J Neurosurg; 2018 Nov; 129(5):1160-1165. PubMed ID: 29271717
[TBL] [Abstract][Full Text] [Related]
3. A method for anticoagulation of children on mechanical circulatory support.
Copeland H; Nolan PE; Covington D; Gustafson M; Smith R; Copeland JG
Artif Organs; 2011 Nov; 35(11):1018-23. PubMed ID: 22097979
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of Antiplatelet Therapy in Children on Ventricular Assist Device Support: Comparison of Multiplate and Thromboelastography Platelet Mapping.
Ferguson LP; Duong P; Pearce KF; Murphy P; Biss TT
ASAIO J; 2019 Jan; 65(1):84-93. PubMed ID: 29489462
[TBL] [Abstract][Full Text] [Related]
6. Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey.
Jennings DL; Horn ET; Lyster H; Panos AL; Teuteberg JJ; Lehmkuhl HB; Perez A; Shullo MA
ASAIO J; 2016; 62(1):28-32. PubMed ID: 26309097
[TBL] [Abstract][Full Text] [Related]
7. Thromboelastography with Platelet Mapping Identifies High Platelet Reactivity is Associated with Obesity, Diabetes, and Thrombotic Events.
Hall R; Suarez S; Majumdar M; Lee I; Zacharias N; Gee D; Dua A
Ann Vasc Surg; 2024 Jul; 104():227-236. PubMed ID: 38490537
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation management following left ventricular assist device implantation is similar across all provider strategies.
McDavid A; MacBrair K; Emani S; Yu L; Lee PHU; Whitson BA; Lampert BC; Agarwal R; Kilic A
Interact Cardiovasc Thorac Surg; 2018 Jan; 26(1):60-65. PubMed ID: 29049614
[TBL] [Abstract][Full Text] [Related]
9. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
12. Fixed-dose aspirin monotherapy compared with thromboelastography directed antiplatelet therapy in long-term management of left ventricular assist devices.
Fanelli SJ; Elzeneini M; Meece LE; Mahmoud A; Jeng EI; Harris N; Ahmed MM
J Card Surg; 2022 Sep; 37(9):2621-2628. PubMed ID: 35610463
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant Bridge Comparison in Mechanical Circulatory Support Patients.
Cosgrove RH; Basken RL; Smith RG; Hsu CH; Kazui T; Martinez BK; Burt RW; Crawford ES; Lick SD; Khalpey Z
ASAIO J; 2019 Jan; 65(1):54-58. PubMed ID: 29324514
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K-dependent coagulation factor deficiency in trauma: a comparative analysis between international normalized ratio and thromboelastography.
Nascimento B; Al Mahoos M; Callum J; Capone A; Pacher J; Tien H; Rizoli S
Transfusion; 2012 Jan; 52(1):7-13. PubMed ID: 21745216
[TBL] [Abstract][Full Text] [Related]
15. Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.
Karimi A; Beaver TM; Hess PJ; Martin TD; Staples ED; Schofield RS; Hill JA; Aranda JM; Klodell CT
Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):457-65. PubMed ID: 24421208
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
17. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.
Franchi F; Hammad JS; Rollini F; Tello-Montoliu A; Patel R; Darlington A; Kraemer DF; Cho JR; DeGroat C; Bhatti M; Taha M; Angiolillo DJ
J Thromb Thrombolysis; 2015 Jul; 40(1):118-25. PubMed ID: 25129122
[TBL] [Abstract][Full Text] [Related]
18. Application of a TEG-Platelet Mapping Algorithm to Guide Reversal of Antiplatelet Agents in Adults with Mild-to-Moderate Traumatic Brain Injury: An Observational Pilot Study.
Kvint S; Gutierrez A; Venezia A; Maloney E; Schuster J; Kumar MA
Neurocrit Care; 2022 Dec; 37(3):638-648. PubMed ID: 35705826
[TBL] [Abstract][Full Text] [Related]
19. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.
Majeed F; Kop WJ; Poston RS; Kallam S; Mehra MR
Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):147-57. PubMed ID: 19174824
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
Netuka I; Litzler PY; Berchtold-Herz M; Flecher E; Zimpfer D; Damme L; Sundareswaran KS; Farrar DJ; Schmitto JD;
Ann Thorac Surg; 2017 Apr; 103(4):1262-1268. PubMed ID: 27743637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
